Literature DB >> 23120494

Is surgical vestibular ablation necessary in disabling peripheral vertigo?

A Mahadevaiah1, Bhavin Parikh.   

Abstract

The use of intratympanic gentamicin is an easily performed office procedure for the conservative treatment of the Meniere's disease patient who has failed medical therapy. The procedure provides excellent control for the symptom of vertigo and is one of the most successful methods in the treatment of vertigo due to inner ear disorders. Surgical ablation is no longer necessary for adequate control of vestibular symptoms and that chemical ablation/alteration may replace the need for surgical vestibular ablation in cases of disabling Meniere's disease and other inner ear causes for peripheral vertigo.

Entities:  

Keywords:  Chemical ablation; Disabling vertigo; Intratympanic gentamicin

Year:  2008        PMID: 23120494      PMCID: PMC3450714          DOI: 10.1007/s12070-008-0010-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  24 in total

Review 1.  Update on intratympanic gentamicin for Meniere's disease.

Authors:  B W Blakley
Journal:  Laryngoscope       Date:  2000-02       Impact factor: 3.325

2.  Titration streptomycin therapy for bilateral Meniére's disease. Follow-up report.

Authors:  A W Langman; J L Kemink; M D Graham
Journal:  Ann Otol Rhinol Laryngol       Date:  1990-11       Impact factor: 1.547

3.  Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens.

Authors:  A A Toth; L S Parnes
Journal:  J Otolaryngol       Date:  1995-12

4.  Intratympanic gentamycin in severe Ménière's disease.

Authors:  K Laitakari
Journal:  Clin Otolaryngol Allied Sci       Date:  1990-12

5.  Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.

Authors:  M Corsten; J Marsan; D Schramm; J Robichaud
Journal:  J Otolaryngol       Date:  1997-12

6.  Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.

Authors:  S D Rauch; J G Oas
Journal:  Laryngoscope       Date:  1997-01       Impact factor: 3.325

7.  Middle ear ototoxic treatment for inner ear disease.

Authors:  L M Odkvist
Journal:  Acta Otolaryngol Suppl       Date:  1989

8.  Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.

Authors:  C L Driscoll; J L Kasperbauer; G W Facer; S G Harner; C W Beatty
Journal:  Laryngoscope       Date:  1997-01       Impact factor: 3.325

9.  Intratympanic gentamicin in bilateral Menière's disease.

Authors:  I Pyykkö; H Ishizaki; S Kaasinen; H Aalto
Journal:  Otolaryngol Head Neck Surg       Date:  1994-02       Impact factor: 3.497

Review 10.  Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.

Authors:  J M Nedzelski; C M Chiong; G Fradet; D A Schessel; G E Bryce; A G Pfleiderer
Journal:  Am J Otol       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.